Wuxi Biologics (Cayman), Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG970081173
HKD
33.48
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
Net Sales
18,822.82
17,755.59
12,401.68
6,306.60
4,517.17
3,001.94
1,866.65
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
18,822.82
17,755.59
12,401.68
6,306.60
4,517.17
3,001.94
1,866.65
Raw Material Cost
11,278.00
9,936.38
6,581.84
3,460.32
2,636.19
1,796.46
1,103.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
5,526.21
6,496.27
5,191.96
2,443.68
1,046.39
736.93
589.72
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
175.13
74.87
47.23
48.02
22.23
0.00
41.15
Selling and Distribution Expenses
2,330.81
1,966.46
1,394.73
816.83
511.63
386.24
202.24
Other Expenses
-483.30
-577.71
-463.47
-215.04
-77.42
-53.64
-54.50
Total Expenditure (Excl Depreciation)
14,477.14
12,696.88
8,581.08
4,618.45
3,442.25
2,383.21
1,391.59
Operating Profit (PBDIT) excl Other Income
4345.7
5058.7
3820.6
1688.1
1074.8999999999999
618.6999999999999
475.09999999999997
Other Income
471.59
836.24
310.30
178.03
224.37
241.84
-73.04
Operating Profit (PBDIT)
6,348.42
7,107.82
4,978.28
2,381.99
1,550.30
1,028.21
542.06
Interest
175.13
74.87
47.23
48.02
22.23
0.00
41.15
Exceptional Items
-30.09
410.35
728.88
387.80
3.99
13.23
-10.68
Gross Profit (PBDT)
7,544.82
7,819.21
5,819.84
2,846.28
1,880.97
1,205.48
763.18
Depreciation
1,531.15
1,212.87
847.38
515.82
251.01
167.64
140.04
Profit Before Tax
4,612.04
6,230.44
4,812.55
2,205.95
1,281.04
873.80
350.18
Tax
666.51
939.45
583.97
306.84
131.87
127.04
58.88
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,756.69
5,140.25
4,083.83
1,897.79
1,149.57
746.91
291.30
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,756.69
5,140.25
4,083.83
1,897.79
1,149.57
746.91
291.30
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
188.84
150.73
144.75
4.28
-3.93
-0.15
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,945.53
5,290.99
4,228.58
1,902.07
1,145.64
746.76
291.30
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
44,405.30
39,349.12
39,485.29
24,382.03
14,300.53
9,115.74
4,831.02
Earnings per share (EPS)
0.86
1.17
0.92
0.45
0.29
0.19
0.08
Diluted Earnings per share
0.86
1.17
0.92
0.45
0.29
0.19
0.08
Operating Profit Margin (Excl OI)
23.09%
28.49%
30.81%
26.77%
23.8%
20.61%
25.45%
Gross Profit Margin
32.64%
41.92%
45.64%
43.16%
33.92%
34.69%
26.26%
PAT Margin
19.96%
28.95%
32.93%
30.09%
25.45%
24.88%
15.61%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2023 is 6.01% vs 43.17% in Dec 2022

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is -25.43% vs 25.12% in Dec 2022

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is -6.30% vs 34.35% in Dec 2022

stock-summary

Interest

YoY Growth in year ended Dec 2023 is 133.78% vs 58.69% in Dec 2022

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Wuxi Biologics (Cayman), Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
18,822.82
31,452.52
-12,629.70
-40.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
18,822.82
31,452.52
-12,629.70
-40.15%
Raw Material Cost
11,278.00
9,444.18
1,833.82
19.42%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
5,526.21
4,744.41
781.80
16.48%
Power Cost
0
0
0.00
Manufacturing Expenses
175.13
47.35
127.78
269.86%
Selling and Distribution Expenses
2,330.81
10,576.50
-8,245.69
-77.96%
Other Expenses
-483.30
83.61
-566.91
-678.04%
Total Expenditure (Excl Depreciation)
14,477.14
25,648.52
-11,171.38
-43.56%
Operating Profit (PBDIT) excl Other Income
4,345.68
5,804.01
-1,458.33
-25.13%
Other Income
471.59
502.20
-30.61
-6.10%
Operating Profit (PBDIT)
6,348.42
7,754.89
-1,406.47
-18.14%
Interest
175.13
47.35
127.78
269.86%
Exceptional Items
-30.09
-113.26
83.17
73.43%
Gross Profit (PBDT)
7,544.82
22,008.35
-14,463.53
-65.72%
Depreciation
1,531.15
1,448.68
82.47
5.69%
Profit Before Tax
4,612.04
6,145.60
-1,533.56
-24.95%
Tax
666.51
1,344.33
-677.82
-50.42%
Provisions and contingencies
0
0
0.00
Profit After Tax
3,756.69
4,692.56
-935.87
-19.94%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
3,756.69
4,692.56
-935.87
-19.94%
Share in Profit of Associates
0
0
0.00
Minority Interest
188.84
11.70
177.14
1,514.02%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,945.53
4,704.26
-758.73
-16.13%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
44,405.30
34,336.48
10,068.82
29.32%
Earnings per share (EPS)
0.86
0.40
0.46
115.00%
Diluted Earnings per share
0.86
0.40
0.46
115.00%
Operating Profit Margin (Excl OI)
23.09%
18.45%
0.00
4.64%
Gross Profit Margin
32.64%
24.15%
0.00
8.49%
PAT Margin
19.96%
14.92%
0.00
5.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 1,882.28 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 6.01% vs 43.17% in Dec 2022

Annual - Consolidate Net Profit
Consolidate Net Profit 394.55 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -25.43% vs 25.12% in Dec 2022

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 587.68 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is -6.30% vs 34.35% in Dec 2022

Annual - Interest
Interest 17.51 Million
in Dec 2023

Figures in Million
stock-summary

YoY Growth in year ended Dec 2023 is 133.78% vs 58.69% in Dec 2022

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.09%
in Dec 2023

Figures in %
stock-summary

YoY Growth in year ended Dec 2023 has fallen from Dec 2022